Cardiac CT's Role in Asymptomatic Patients With Diabetes and Metabolic Syndrome

University of California, Irvine193 enrolled

Overview

This study looked at the role of cardiac CT in improving risk factor control in those with diabetes.

This study examined whether doing a cardiac screening test, the cardiac CT, would result in patients paying more attention to controlling their risk factors.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

193

Conditions

Diabetes Metabolic Syndrome

Interventions

Cardiac CTDIAGNOSTIC_TEST

A cardiac CT involves a non-invasive test of the coronary arteries.

Usual medical careBEHAVIORAL

Patients would be treated by their primary care physicians with usual medical care with drugs such as lipid lowering medication, blood pressure lowering medications, and blood glucose lowering medications. The study will not specify which drugs to use and will it up to the individual physician's discretion.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Age \> 18 * Diabetes * Metabolic Syndrome Exclusion Criteria: * Symptoms of heart disease * Heart Disease * Renal disease

Locations (1)

University of California, Irvine Medical Center

Orange, California, United States

Outcomes

Primary Outcomes

Systolic BP Pressure

After randomization to either obtain cardiac CT or usual care, patients will be followed for 5 years (with assessment of outcomes at every 6 months) to see any difference in control of systolic blood pressure. The outcome with be assessed as a continuous measure.

Time frame: Five year follow up

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.